Investigational Drug Details
| Drug ID: | D314 |
| Drug Name: | RYI-018 |
| Synonyms: | Nimacimab |
| Type: | Biological drug |
| DrugBank ID: | DB15115 |
| DrugBank Description: | Nimacimab is under investigation in clinical trial NCT03261739 (Safety Tolerability, and PK of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)). |
| PubChem ID: | -- |
| CasNo: | 2098636-09-8 |
| Repositioning for NAFLD: | No |
| SMILES: | -- |
| InChiKey: | -- |
| Molecular Weight: | -- |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | -- |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 1 completed (NCT03261739) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0112 | NCT03261739 | Phase 1 | Completed | No Results Available | August 28, 2017 | March 14, 2019 | Details |
| L0994 | ACTRN12617000133336 | Phase 1 | Recruiting | No Results Available | -- | -- | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|